Article Versions Notes

Radke L, Sandig G, Lubitz A, Schließer U, Von Horsten HH, Blanchard V, Keil K, Sandig V, Giese C, Hummel M, et al. In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor. Bioengineering. 2017; 4(3):70. https://doi.org/10.3390/bioengineering4030070

Radke, Lars, Grit Sandig, Annika Lubitz, Ulrike Schließer, Hans Henning Von Horsten, Veronique Blanchard, Karolin Keil, Volker Sandig, Christoph Giese, Michael Hummel, and et al. 2017. "In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor" Bioengineering 4, no. 3: 70. https://doi.org/10.3390/bioengineering4030070

Radke, L., Sandig, G., Lubitz, A., Schließer, U., Von Horsten, H. H., Blanchard, V., Keil, K., Sandig, V., Giese, C., Hummel, M., Hinderlich, S., & Frohme, M. (2017). In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor. Bioengineering, 4(3), 70. https://doi.org/10.3390/bioengineering4030070